Lipoprotein-associated phospholipase A2 levels as a predictor of cardiovascular risks in patients with COPD and obstructive sleep apnea

Lipoprotein-associated phospholipase A2 levels as a predictor of cardiovascular risks in patients with COPD and obstructive sleep apnea

Background: Lipoprotein-associated phospholipase A2 (Lp-PLA2) is an inflammatory mediator used as a novel marker for vascular specific inflammation, atherosclerosis and cardiovascular risks in humans. Both chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea (OSA) are associated...

Full description

Bibliographic Details
Main Authors: Eman A.E. Badr, Maha Yousif, Suzan M. Hazzaa
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2014-04-01
Series:Egyptian Journal of Chest Disease and Tuberculosis
Subjects:
Cardiovascular disease
COPD
Inflammation
Respiratory neurobiology and sleep
Sleep apnea
Online Access:http://www.sciencedirect.com/science/article/pii/S0422763814000430

Internet

http://www.sciencedirect.com/science/article/pii/S0422763814000430

Similar Items